| Literature DB >> 17543521 |
Basil Hartzoulakis1, Sharon Rossiter, Herpreet Gill, Bernard O'Hara, Emily Steinke, Paul J Gane, Ramon Hurtado-Guerrero, James M Leiper, Patrick Vallance, Judith Murray Rust, David L Selwood.
Abstract
An efficient process for the discovery of inhibitors of DDAH enzymes, without the requirement for high throughput screening, is described. Physicochemical filtering of a 308,000-compound library according to drug likeness followed by reciprocal nearest neighbour selection produced a representative subset of 35,000 compounds. Virtual screening on a dual processor PC using FlexX, followed by biological screening, identified two hit series. Similarity searches of commercial databases and chemical re-synthesis of pure compounds resulted in SR445 as an inhibitor of Pseudomonas aeruginosa DDAH at 2 microM.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17543521 DOI: 10.1016/j.bmcl.2007.04.095
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823